Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) Automated System for Drug Susceptibility Testing of Mycobacterium Tuberculosis

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2001 Nov 29

PMID 11724858

Citations 56

Authors

F Ardito

B Posteraro

M Sanguinetti

S Zanetti

G Fadda

Affiliations

Soon will be listed here.

Abstract

The reliability of the BACTEC MGIT 960 system, an automated version of the Mycobacteria Growth Indicator Tube (MGIT), for antimicrobial susceptibility testing of Mycobacterium tuberculosis was evaluated on 78 clinical isolates. Rifampin (RMP), isoniazid (INH), streptomycin (SM), and ethambutol (EMB) were tested at the following concentrations: 1.0 microg/ml for RMP, 0.1 and 0.4 microg/ml for INH, 1.0 and 4.0 microg/ml for SM, and 5.0 and 7.5 microg/ml for EMB. Results were compared with those obtained by the BACTEC 460 TB radiometric system. Initially the reproducibility study showed 99.5% agreement on repeat testing with all the four drugs. With susceptibility testing of clinical isolates, excellent agreement between the two systems was found for all the drugs. A total of nine major errors were observed for only three isolates, resistant according to BACTEC MGIT 960 and susceptible according to BACTEC 460 TB, to SM (4.0 microg/ml), INH (0.1 microg/ml), and EMB (5.0 microg/ml) (one isolate) and to SM (1.0 microg/ml), INH (0.4 microg/ml), and EMB (5.0 microg/ml) (two isolates). When these isolates were tested by using the conventional proportion method on Löwenstein-Jensen medium, agreement with BACTEC MGIT 960 was found for five results and with BACTEC 460 TB for the remainder. The time to report results was 7.9 days by MGIT 960 and 7.3 days by BACTEC 460 TB, which was not found statistically significant (P > 0.05). In conclusion, the performance of BACTEC MGIT 960 was found similar to that of BACTEC 460 TB and this new system can be considered a good alternative to the radiometric method for routine susceptibility testing of M. tuberculosis.

Citing Articles

Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant compared to linezolid.

Ilchenko O, Nikolaevskaya E, Zinchenko O, Ivanytsia V, Prat-Aymerich C, Ramstedt M Front Microbiol. 2024; 15:1474071.

PMID: 39697659 PMC: 11654424. DOI: 10.3389/fmicb.2024.1474071.

CRISPR for companion diagnostics in low-resource settings.

Qian X, Xu Q, Lyon C, Hu T Lab Chip. 2024; 24(20):4717-4740.

PMID: 39268697 PMC: 11393808. DOI: 10.1039/d4lc00340c.

Multi-drug resistant gene mutation analysis in by molecular techniques.

Sultana M, Alam M, Mistri S, Mostafa Kamal S, Ahsan C, Yasmin M Iran J Microbiol. 2024; 16(4):459-469.

PMID: 39267928 PMC: 11389769. DOI: 10.18502/ijm.v16i4.16304.

Epidemiology of multi-drug resistant Tuberculosis in the western region of Kenya.

Lugonzo G, Njeru E, Songock W, Okumu A, Ndombi E AIMS Microbiol. 2024; 10(2):273-287.

PMID: 38919722 PMC: 11194625. DOI: 10.3934/microbiol.2024014.

Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.

Suresh P, Thulasidharan S, Kumar A, Sunil S, Roy M, Ramesh V Am J Trop Med Hyg. 2024; 111(1):161-167.

PMID: 38772358 PMC: 11229631. DOI: 10.4269/ajtmh.24-0042.

References

Sreevatsan S, Stockbauer K, Pan X, Kreiswirth B, Moghazeh S, Jacobs Jr W . Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother. 1997; 41(8):1677-81. PMC: 163984. DOI: 10.1128/AAC.41.8.1677. View

Palaci M, Ueki S, Sato D, da Silva Telles M, Curcio M, Silva E . Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J Clin Microbiol. 1996; 34(3):762-4. PMC: 228889. DOI: 10.1128/jcm.34.3.762-764.1996. View

Alcaide F, Pfyffer G, Telenti A . Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother. 1997; 41(10):2270-3. PMC: 164105. DOI: 10.1128/AAC.41.10.2270. View

Bergmann J, Woods G . Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin. J Clin Microbiol. 1997; 35(12):3325-7. PMC: 230176. DOI: 10.1128/jcm.35.12.3325-3327.1997. View

Pablos-Mendez A, Raviglione M, Laszlo A, Binkin N, Rieder H, Bustreo F . Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med. 1998; 338(23):1641-9. DOI: 10.1056/NEJM199806043382301. View

Sanguinetti M, Posteraro B, Ardito F, Zanetti S, Cingolani A, Sechi L . Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol. 1998; 36(6):1530-3. PMC: 104871. DOI: 10.1128/JCM.36.6.1530-1533.1998. View

Chew W, Lasaitis R, Schio F, Gilbert G . Clinical evaluation of the Mycobacteria Growth Indicator Tube (MGIT) compared with radiometric (Bactec) and solid media for isolation of Mycobacterium species. J Med Microbiol. 1998; 47(9):821-7. DOI: 10.1099/00222615-47-9-821. View

Rusch-Gerdes S, Domehl C, Nardi G, Gismondo M, Welscher H, Pfyffer G . Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol. 1998; 37(1):45-8. PMC: 84164. DOI: 10.1128/JCM.37.1.45-48.1999. View

Hanna B, Ebrahimzadeh A, Elliott L, Morgan M, Novak S, Rusch-Gerdes S . Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol. 1999; 37(3):748-52. PMC: 84542. DOI: 10.1128/JCM.37.3.748-752.1999. View

10.

Cingolani A, Antinori A, Sanguinetti M, Gillini L, De Luca A, Posteraro B . Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis. 1999; 179(4):1025-9. DOI: 10.1086/314677. View

11.

Tortoli E, Cichero P, Piersimoni C, Simonetti M, Gesu G, Nista D . Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol. 1999; 37(11):3578-82. PMC: 85696. DOI: 10.1128/JCM.37.11.3578-3582.1999. View

12.

Alcaide F, Benitez M, Escriba J, Martin R . Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J Clin Microbiol. 2000; 38(1):398-401. PMC: 88732. DOI: 10.1128/JCM.38.1.398-401.2000. View

13.

Bergmann J, FISH G, Woods G . Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs. Arch Pathol Lab Med. 2000; 124(1):82-6. DOI: 10.5858/2000-124-0082-EOTBMM. View

14.

Katila M, Katila P . Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems. J Clin Microbiol. 2000; 38(3):960-4. PMC: 86313. DOI: 10.1128/JCM.38.3.960-964.2000. View

15.

Heifets L, Linder T, Sanchez T, Spencer D, Brennan J . Two liquid medium systems, mycobacteria growth indicator tube and MB redox tube, for Mycobacterium tuberculosis isolation from sputum specimens. J Clin Microbiol. 2000; 38(3):1227-30. PMC: 86383. DOI: 10.1128/JCM.38.3.1227-1230.2000. View

16.

Ardito F, Sanguinetti M, Sechi L, Posteraro B, Masucci L, Fadda G . Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis. New Microbiol. 2000; 23(2):151-8. View

17.

Whyte T, Hanahoe B, Collins T, Corbett-Feeney G, Cormican M . Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis. J Clin Microbiol. 2000; 38(8):3131-2. PMC: 87212. DOI: 10.1128/JCM.38.8.3131-3132.2000. View

18.

van Soolingen D, de Haas P, van Doorn H, Kuijper E, Rinder H, Borgdorff M . Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis. 2000; 182(6):1788-90. DOI: 10.1086/317598. View

19.

Woods G . Susceptibility testing for mycobacteria. Clin Infect Dis. 2000; 31(5):1209-15. DOI: 10.1086/317441. View

20.

Siddiqi S, Libonati J, MIDDLEBROOK G . Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 1981; 13(5):908-12. PMC: 273915. DOI: 10.1128/jcm.13.5.908-912.1981. View